Get started

Undervalued

FSM a silver junior miner poised to profit on silver's momentum FSM is on a 30-minute chart. The trade idea is that FMS suffers in drops in spot sliver but thrives when spot silver rises as its fixed expenses in mining allow for increases in margin in a curvilinear fashion when spot silver rises. This is more so than a senior miner such as FCX that moves slower when metal prices rise or fall. I see the quick geopolitical dip in spot silver as an opportunity to pick up junior miners ( including GDXJ the ETF) at a discounted price to be held for spot silver recovery and then averaged out for realization of profits.
NYSE:FSMLong
by AwesomeAvani
2
Chainlink (LINK): Oversold and Undervalued. Surge to $37+Finally, after a long wait, we got filled on Chainlink, and we entered at $12.93. This is our entry point. The entry is holding up quite well and solid so far. We still see strength in Chainlink and we do not believe that our large stop-loss will be triggered. Also, for the first time since May 2022, the RSI has fallen into the oversold area, which is another sign of how strongly Chainlink has been sold off. We are holding on to this and still expect an increase to at least $37.45, probably even to $47.45.
CRYPTO:LINKUSDLong
by freeguy_by_wmc
EL jumps on analyst upgrade LONGEL like ULTA was beaten down in covid times. It jumped in 2021 and fell in 2022 and 2023. 2024 might be the year they thrive again. On the weekly chart, EL is back to the support of its levels of 2018. With an analyst upgrade coming from Bank of America it is now getting a bit of attention. Trend strength and relative strength were down. I see this as a good entry for a new long position in EL while also looking at ULTA. Targets are the fib zone and a correction / consolidation area on the downtrend so 200 and 250. Now is the time to invest in female beauty.....
NYSE:EL
by AwesomeAvani
RH appears ready to rise from its base LONGRestoration Hardware on the weekly chart rose from COVID and then retraced for almost two years. It appears now ready to experience some investor and trader interest once again. It is rising from the POC line of its long term volume profile. The trend strength indicator just inflected and curled upward. I like to catch trends early to get as much of a move as possible and before the chasing begins. This is a possible megacap short squeeze set up. Targets are 380 and 480 as horizontal levels of importance.
NYSE:RHLong
by AwesomeAvani
SoFi's Surge: Unveiling 2023 and What Lies Ahead in 2024Technical Analysis Overview Current Price : $10.34, a 3.77% increase. Weekly Trend : Showing a positive trend with a 5.35% increase over the last five days. 1-Month Trend : A significant increase of 51.96%, indicating strong bullish sentiment. 6-Month and Yearly Trends : A 17.04% increase over the last six months and a 124.51% increase year to date, highlighting a robust bullish trend. Advanced Technical Indicators Relative Strength Index (RSI) : 70.41 - Indicating that SOFI is nearing overbought territory, which could lead to a potential reversal or consolidation in the short term. Moving Average Convergence Divergence (MACD) : 0.63 - Suggesting bullish momentum, indicating a strong buying trend. Other Indicators : STOCH (83.28), STOCHRSI (84.02), ADX (37.09), Williams %R (-8.57), CCI (104.63), ATR (0.46), Ultimate Oscillator (54.76), and ROC (24.66) all contribute to a picture of current bullish momentum but with potential for short-term volatility or pullback. Market Sentiment and External Factors Market Capitalization : $9.904B USD. Trading Volume Analysis : A high trading volume of 35,199,288, suggesting active market participation and interest in the stock. Recent News Coverage Impacting SOFI Bullish Outlook for 2024 : Analysts predict SOFI stock could continue its rally in the new year, benefiting from expected interest-rate cuts. A notable analyst has set a high price target of $14 for SOFI stock, implying significant upside potential ( InvestorPlace ). Focus on Non-Lending Businesses : Analysts appreciate SoFi's shift towards non-lending businesses, improving earnings quality despite a higher-for-longer interest-rate policy. Central Bank Policy Changes : Potential interest rate cuts in 2024 could benefit SoFi's lending business, as lower rates tend to spur borrowing and lending activity. Conclusion SOFI's stock shows strong bullish signs in the medium to long term, but the current overbought condition warrants caution for short-term traders. The recent news and analyst predictions provide a positive outlook for 2024, making SOFI an interesting stock for both traders and long-term investors.
NASDAQ:SOFILong
by Terrapins
7
NVAX- a medical penny stock Buy Weakness LONGNVAX on a 120 minute chart demonstrates a trend down in the past month after a period of consolidation producing the POC line on the volume profile. The MACD shows some bullish divergence. The volume profile has high volume nodes at 4.0 and 5.0 separated by a relative volume void. NVAX fell quickly through that void. It can just as easily rise through it. See the linked article on NVA from TipRanks. Options volume and pricing analysis is that bets are looking at5.0 diligently. Fundamentally, NVAX has been range limited by its focus on COVID but it does have other projects in its pipeline admittedly on various timelines with varying probabilities of capitalizing on them depending on clinical trials FDA approvals and so on. On the imbedded relative strength table as compared with SPY and peers in the pharmaceutical, biotechnology, medical device and healthcare spaces NVAX compares favorably with MRNA its closest peer but is weak compared with most of the others I have selected especially with LLY, which is high-flying from its anti-obesity drug breakout. Device companies Stryker and Intuitive Surgical are quite strong as well. United Healthcare is dominant in the insurance subsector and strong overall. One often effective strategy is to buy when an instrument is oversold and undervalued at a discount. I will buy NVAX here no matter that I have insider connections with one of those medical device companies and a few not on the list. Sentiment only goes so far. I found the article compelling and so Novavax long I go. On a trading site left unsaid my screenname is "Bottom Feeding Grinder". I have an appetite for NVAX found at the bottom right now. This is a reversal/reversion to the mean long trade. It is not without risk. As a penny stock with high volumes, low cost of entry and perhaps low floats, volatility is underscored and exaggerated if a volume inflow gets underway That said, a short squeeze is within the spectrum of possibilities. Enough said for now.
NASDAQ:NVAXLong
by AwesomeAvani
GE Buy the Pullback ( Flip the switch) now LONG I previously published the idea of shorting GE. It has now pulled back more than 4% on the retreacement. The short idea paid well using put options to profit from the pump of earnings expectations. Earnings were great but the run up was too much for traders. GE has now retreated and is ready for a long entry. Price is now in the undervalued range of both the short and intermediate term VWAP bands. The target is $99.99which is basically the price immediately before the earnings report. Confirmation is tbe zero lag MACD where the K/D lines crossed under the histogram and are heading together to cross over the zero line while the histogram flipped from negative to positive. Call options in the money expiring 5/5 are considered.
NYSE:GELong
by AwesomeAvani
4
ROKU falls after an earnings beat dissapointmentROKU on the 30 minute chart had a sell-off after earnings which were okay not great. Traders reacted. The question is whether it was an overreaction. I think it was. I am looking for a slow recovery over a week or more to at least the standard retracement level which I will call 98 as drawn by the tool. further upside targets are 101 and 104 based on VWAP bandlines. Buying on the discount is sometimes an excellent tool to reduce risk and use the reversion to the mean to best advantage and seize an overreaction in the market.
NASDAQ:ROKULong
by AwesomeAvani
Morgan Stanley rated A the Ping An Insurance for secong year Revenue: $156.2 billion Net Income: $14.7 billion Market Cap: $114.8 billion 1-Year Trailing Total Return: ~7.5% Exchange: OTC Markets According to Investopedia, it is the 3rd biggest Chinese company and in the top 5 insurance companies in the world Ping An Insurance provides insurance, financial services, and banking. It is one of the top 50 companies on the Shanghai Stock Exchange. Founded in 1988, it was China's first joint-stock insurance company. Its subsidiaries include Ping An Life, Ping An Property & Casualty, Ping An Annuity, and Ping An Health. Hong Kong and Shanghai, Nov. 29, 2023 /PRNewswire/ -- Ping An Insurance (Group) Company of China, a powerhouse in the insurance sector, proudly declares its stellar achievement in the latest Environmental, Social, and Governance (ESG) Ratings by Morgan Stanley Capital Investment (MSCI). Securing an A rating for the second consecutive year, Ping An reaffirms its commitment to sustainable practices. Notably, the Group maintains its top-tier position in the multi-line insurance & brokerage industry in the Asia-Pacific (APAC) region. This accolade underscores Ping An's unwavering dedication to excellence and responsible corporate citizenship. Investors take note of Ping An's remarkable ESG track record as it continues to lead the way in the industry. Ping An takes proactive steps in addressing climate change challenges, utilizing its integrated finance capabilities to advance green finance initiatives and support China's ambitious targets of achieving "carbon peak and neutrality in 2030 and 2060 respectively." In responsible investment, Ping An implements the active ownership principle, integrating Environmental, Social, and Governance (ESG) factors into research, analysis, and investment decisions. The company actively oversees and participates in ESG management for portfolio companies, ensuring their healthy development. By June 2023, Ping An's green investments in insurance assets reached an impressive RMB140.929 billion. The current entry-level is looking promising being close to the all-time lows with much higher upside potential than the downward one.
OTC:PNGAYLong
by Elite_Forex
The Bullish Case for TESLAOne of the biggest misconception on Tesla is that it is just an Electric Vehicle Company but that is not the case. Tesla is also a Robotics, AI and energy company. If you look at it from that lens, TESLA is undervalued and has a great future!! TESLA recently bounced off the $212 Support level and believe this is the start of a bullish trend. Targeting the $300 Price point and we may even see $300 by the end of 2024. For context Elon recently tweeted this on TESLA "I am uncomfortable growing Tesla to be a leader in AI & robotics without having ~25% voting control. Enough to be influential, but not so much that I can't be overturned. Unless that is the case, I would prefer to build products outside of Tesla. You don't seem to understand that Tesla is not one startup, but a dozen. Simply look at the delta between what Tesla does and GM. As far as stock ownership itself being enough motivation, fidelity, and other similar stakes to me, why don't they show up for work?" In this tweet, Elon Musk expresses his desire for greater control over Tesla's direction as the company expands into AI and robotics. He believes that his current 13% stake in the company is not enough to make significant decisions in these areas. Tesla has a great future and as long as Elon is the captain, this ship will continue to go to mars and beyond. cheers
NASDAQ:TSLALong
by EgideSimba
4
Is Sanofi Undervalue by 22% ?I wanted to share an analysis I've conducted on Sanofi over the past five years using both comparable methods and a 2-Stage DCF approach. According to my findings, the market value appears to be at least 22% undervalued in comparison with its fair value. Moreover, considering the post-COVID effects on pharmaceutical companies, I believe Sanofi presents a compelling opportunity to purchase its stock with potentially lower risk. I would be glad to share my detailed analysis for any one interested in more in debt explorations Disclaimer: This information is based on my personal analysis and is not to be considered financial advice. I am expressing my own views and opinions on the current market conditions and Sanofi's stock. Always conduct your own research and consider seeking advice from a qualified financial professional before making any investment decisions.
EURONEXT:SANLong
by arya1992
XDB Accumulation - with XDB/BTC pairing.Accumulating XDB and running it in XDB/BTC pairing bots.. It is my coin for the year that may turn around and is finding it's bottom, if it hasnt already done so. Current info - XDB is an active project with updates informed vua Twitter and Medium - It is a payment system that offers 10-15% in rewards after its used for a purchase at this time. - They just launched payments in ASRoma, Doppleganger and Nuvolari (50 or so) stores. according the their Twitter handle Digitalbitsorg. - In ... I believe MEXC AMA, they teased a large 900+ location brand chain that they are working with to launch Digibits for payments and rewards. - Uses AtraX wallet - It was primarily traded on Kucoin and Gate.io, but in the past month or two it has been listed on MEXC, CoinDCX, BTCEX, Deepcoin, etc. - Also according to their Twitter, "#Defi is coming. AMM and liquidity pools are part of the V18 update, which is in testnet." - Tokenomics roughly 3b/20b circulting. Some have been burned, some donated to Ukraine (address untouched since donation as of now). - A token release/minting schedule is unknown. I've been accumulating for a month or two.It has an ATH of 0.84 and is currently trading at ~0.00138. I'll be accumulating 0.0002-0.006. It's All time low is 0.00113147 on Kucoin. Which is down 99.xx%. Given the project being active, payments/rewrds available in a growing list of new stores, and DEFI in testnet the project appears to be undervalued. Weekly volume since October 2022-current is roughly 50x when copared to 2021 when it had it's high of 0.84 which is good news, but the Tokenomics needs to be monitored.
Long
by TheRediJedi
2
$REE - 3 month bottom base formed, ready for a boom!REE Automotive has formed a base ~4$ for the past 3 months. It has announced partnerships with Magna International, American Axle, Hino, Hitachi, J.B. Poindexter, Mitsubishi, Navya, Maxion, and more. Rumors around a UPS partnership as well. January 5-8 is CES in which they will be displaying their autonomous vehicle named Leopard and their FlatFormer base. It was originally a SPAC valued at 10$ NAV that hit around 16$. The technology and partnerships are becoming hard to ignore. This is not financial advice and is my own opinion. I have a holding in REE.
NASDAQ:REELong
by Croaking
Discounted GrowthRev Growth YoY and FWD are 50 and 23% respectively and 307 and 167% above the sector respectively while PE GAAP TTM and FWD are 71 and 65% below sector! This implies a huge discount in growth. Gross Profit does lag behind the sector by about 12%, but the valuation combined with the outsized growth substantially off-sets this disparity. On a technical note, there is an intermediary "W" pattern. Confirmation of this pattern would be realized once the SP closes above the midpoint peak of @25.75 along w/ substantial volume, 3 day rule, etc. Pattern and targets are also correlated with Fibonacci retracement levels and Fib Time series.
NASDAQ:AALLong
by Jrussell86
(ASX: $SPQ) ASX:SPQ Potential move to Z2 (Zone 2), due to increasing bullish volume, interest from retail, and organisational bodies. I don't think we'll see major moves in share price until we get some interesting market news. Top 20 Holders have remained the same over the last 2 years, current price reduction represents retail investors cutting losses. Despite having positive market news in April, sophisticated investors did offload some of their shares, not for a huge profit, but in order to buy back in at a lower price. ASX:SPQ Recently raised $4M AUD to proceed with further drilling and exploration projects. Options have been released with an execution price of 0.06c before Nov 24. This can be viewed positively, as the company is confident in its short to medium term capability, and is expecting to please investors. The top 20 Holders own roughly 31% of market share, considering they have remained the same over the last 2 years, we can be confident that they aren't going to dump huge volume on us retail investors. We can use the RSI to visualise how the institutions are maintaining a level of support at this key level, hopefully pulling us out of this 3 stage downtrend. I'll try and update this Idea as we get more information from the company in this exciting time!
ASX:SPQLong
by boiledpeas
Undervalued GrowthCOHR caught my attention for a few reasons. 1st. It is ≈11% of total holding of Scion Asset Mngt holdings, one of the best performing funds since 2008. 2. Technical: SP trading in demand zone, appearing to possibly be in process of forming a double bottom- confirmed on 3 day rule, vol, etc. passing 46.46 area. 3. Valuation: Currently at steep discount to competitors despite continual growth in earnings. significantly below sector by almost every metric... EV/EBITDA TTM 16% below; FWD- 40% below, P/S TTM/ FWD- 63/65% respectively, Price/ CF- 79% below. Trading about 50% below 5 year PB and 55% 5 year P/Cash flow. 4. Growth: Rev Growth YoY 177% above sector; FWD-116% above sector, significantly above sector by almost every metric besides ROE.
NYSE:COHRLong
by Jrussell86
1
Inflection PointBKI caught my attention for a few reasons. 1. Held by Scion Asset Mngt- if you haven't heard of them or Michael Burry, check it out. Crazy returns off the financial Crisis. 2. SP sitting at an inflection point at bottom of long term demand zone and near lowest long term demand zone. 3. BKI's shiller PE ratio range over the past 10 years is from 36.26-43.09 and currently sitting at 37.37 implying that it is near its lowest valuation in 10 years. 4. Mornings Star Fair Value market valuation sitting at $61.1. My own target of $77.5 is based on a Fibonacci retrace of 61.8% of 2020 highs.
BLong
by Jrussell86
Technical Pull back Buy the DIP!The slight gross margin decrease of 4.8% was enough to resume the HS pattern on the chart executing a normal pullback- relative to the "neckline" where HS patterns are confirmed with some other criterion. Despite the quarterly margin contraction, expected cost reductions should start to materialize in 2024. Everything on the income statement is trending in the right direction. If TSLA really does hit the pattern target of HKEX:80 , a 50% further decrease from current SP, which is based on a formula of probabilities for this specific pattern, then it will be 62% undervalued. At SP of 80, subtracting the 5.14 of Cash per share, and using current TTM, the PE would be 21! Even with a PE of 49 GAAP TTM , the difference to sector is 222% and FWD PE of 50.5. However several different metrics between growth and profitability could easily justify it where its at now. EBITDA growth YoY 3,607% diff to sector,/ FWD 690% diff to sector; Rev Growth Fwd 393%. EV/EBIDTA FWD 180 % diff to sector. Net Income Margin TTM 247% diff to sector. ROC TTM 193 and ROA TTM 289% differences to sector... Easily justified.. Rarely are you able to purchase growth companies at a PE of 21... Buy the DIP!
NASDAQ:TSLALong
by Jrussell86
Breakout on Battery Production NewsPositive divergence can be seen on a yearly basis with MACD leveling out crossing into positive territory. SP appears to have formed a double bottom and is currently breaking out from a narrower down trend. Currently, the SP is ≈33% below the average analyst target and ≈45% below the top range of down channel primary trend. The SP collapsed last year as a result of the public offering in December, cash burn rate and a gross loss for the most recent quarter. Revenue YoY has grown 142% and revenue growth FWD is 118%. With the high growth rate and being profitable on a yearly basis, a PE of 22 is cheap.
LLong
by Jrussell86
Is Solar Integrated Roofing (OTCPK: SIRC) an undervalued stock?Solar Integrated Roofing Corp (OTCPK: SIRC) stock gained 27% on February 2nd and saw a total gain of 100% in the last one week. The company announced a $25 million drawdown term note from an institutional investor with a 6% interest rate and a 5% discount. The CEO believes the term note and cost control efforts will help optimize operating cash flows and profitability, leading to sustainable, long-term value for shareholders. Solar Integrated Roofing Corporation specializes in solar roofing systems and has seen a significant increase in sales and net income in recent quarters
OTC:SIRCLong
by FDGT_academy
1